기능성 소화불량 치료제 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 연간 평균 성장률(CAGR) 6.6%로 성장할 전망이며, 118억 달러로 성장이 예상됩니다. 예측 기간 동안의 성장은 포괄적이고 라이프스타일에 기초한 접근 방식에 대한 소비자 기호 증가, 병용 요법에 대한 기호 증가, 라이프스타일 수정의 채택 증가, 장뇌축에 관한 연구 확대, 비약리학적 개입의 사용 증가에 기인할 것으로 보입니다. 이 기간에 예상되는 주요 동향으로는 약제 제형 진보, 헬스케어 공급자 및 제약기업 연계, 정밀의료 접근방식으로의 전환, 원격의료 및 디지털 헬스기술의 통합, 개별화 의료 전략 등을 들 수 있습니다.
알코올 소비량 증가가 기능성 소화불량 치료제 시장의 성장을 밀어 올릴 것으로 예측됩니다. 맥주, 와인, 증류주 등의 음료에 포함된 알코올은 에탄올로 구성되어 있으며 섭취 시 중추신경계에 영향을 미쳐 중독 증상을 일으킬 수 있습니다. 알코올 소비 증가는, 사회적 및 문화적 수용, 스트레스 해소, 입수의 용이성, 알코올 음료 회사에 의한 적극적인 마케팅 등의 요인에 의해서 초래되고 있습니다. 기능성 소화불량 치료제는 알코올로 인한 위의 불편함을 완화하기 위해 위산 분비를 억제하고 소화 기능을 개선하는 목적으로 사용됩니다. 예를 들어 영국 정부기관인 OHID(Office for Health Improvement & Disparities)가 2023년 3월 발표한 보고서에 따르면 2021-2022년 알코올에만 관련된 입원환자 수는 34만 2,795명으로 인구 10만 명당 입원환자 수는 626명에 이르는 것으로 나타났습니다. 이처럼 알코올 소비량의 증가가 기능성 소화불량 치료제 시장의 성장에 기여하고 있습니다.
대사성 질환의 유병률 증가는 기능성 소화불량 치료제 시장의 확대를 촉진할 것으로 예측됩니다. 대사장애는 체내의 정상적인 대사과정이 흐트러져 영양소와 에너지, 노폐물의 처리에 불균형이 생기면서 발생합니다. 식생활의 혼란, 앉기 쉬운 라이프 스타일, 유전적 소인, 비만율 상승 등의 요인이 이러한 질환의 유병률 상승에 기여하고 있습니다. 기능성 소화불량 치료제는 대사 장애를 가진 사람의 위장 증상을 관리하고 소화 기능을 개선하기 위해 사용됩니다. 예를 들어 세계보건기구(WHO)가 2024년 11월 발표한 보고서에 따르면 2022년에는 18세 이상 성인의 14%가 당뇨병 진단을 받았습니다. 따라서 대사성 질환의 유병률 상승이 기능성 소화불량 치료제 시장의 성장을 촉진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장-거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
- 세계의 기능성 소화불량 치료제 시장 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계의 기능성 소화불량 치료제 시장 : 성장률 분석
- 세계의 기능성 소화불량 치료제 시장 실적 : 규모 및 성장(2019-2024년)
- 세계의 기능성 소화불량 치료제 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
- 세계의 기능성 소화불량 치료제 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 기능성 소화불량 치료제 시장 : 약제 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 양성자 펌프 억제제
- H-2 수용체 길항제
- 제산제
- 항생제
- 프로키네틱스
- 항우울제
- 세계의 기능성 소화불량 치료제 시장 : 적응증별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 기능성 디스펙시아
- 기질성 디스펙시아
- 세계의 기능성 소화불량 치료제 시장 : 유통 채널별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 소매 약국
- 병원 약국
- 온라인 약국
- 세계의 기능성 소화불량 치료제 시장 : 양성자 펌프 억제제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 오메프라졸
- 에소메프라졸
- 란소프라졸
- 판토프라졸
- 라베프라졸
- 세계의 기능성 소화불량 치료제 시장 : H2 수용체 길항제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 라니티딘
- 파모티딘
- 시메티딘
- 니자티딘
- 세계의 기능성 소화불량 치료제 시장 : 제산제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 수산화알루미늄
- 수산화마그네슘
- 탄산칼슘
- 중탄산나트륨
- 세계의 기능성 소화불량 치료제 시장 : 항생물질 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 클라리스로마이신
- 아목시실린
- 메트로니다졸
- 테트라 사이클린
- 세계의 기능성 소화불량 치료제 시장 : 프로키네틱스 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 돈페리돈
- 메토클로프라미드
- 이토프리드
- 모사프리드
- 세계의 기능성 소화불량 치료제 시장 : 항우울제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 삼환계 항우울제
- 선택적 세로토닌 재흡수 억제제
- 세로토닌 노르 에피네프린 재흡수 억제제
제7장 지역별 및 국가별 분석
- 세계의 기능성 소화불량 치료제 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 기능성 소화불량 치료제 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
- 기능성 소화불량 치료제 시장 : 경쟁 구도
- 기능성 소화불량 치료제 시장 : 기업 프로파일
- Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
- Abbvie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
- Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
- AstraZeneca plc : 개요, 제품 및 서비스, 전략 및 재무 분석
- Astellas Pharma Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Eisai Co. Ltd.
- Menarini Group
- Dr. Reddy's Laboratories Ltd.
- Lupin Limited
- Daewoong Pharmaceutical Co. Ltd.
- Phathom Pharmaceuticals
- Zeria Pharmaceutical Co. Ltd.
- Ironwood Pharmaceuticals Inc.
- Salix Pharmaceuticals Inc.
- RedHill Biopharma
- RaQualia Pharma Inc.
- MetaMe Health
- Renexxion LLC
- Processa Pharmaceuticals
- Evoke Pharma Inc.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
- 기능성 소화불량 치료제 시장(2029년) : 새로운 기회를 제공하는 국가
- 기능성 소화불량 치료제 시장(2029년) : 새로운 기회를 제공하는 부문
- 기능성 소화불량 치료제 시장(2029년) : 성장 전략
제36장 부록
AJY
Functional dyspepsia drugs are a category of medications used to manage and relieve symptoms related to functional dyspepsia (FD), a gastrointestinal disorder marked by persistent or recurring upper abdominal discomfort without a clear structural or biochemical cause. These medications are designed to alleviate symptoms such as bloating, early satiety, nausea, and epigastric pain.
The primary types of drugs used to treat functional dyspepsia include proton pump inhibitors, H-2 receptor antagonists, antacids, antibiotics, prokinetics, and antidepressants. Proton pump inhibitors (PPIs) are a specific type of medication that reduce stomach acid production by inhibiting the action of the gastric proton pump (H+/K+-ATPase) in the stomach lining. These treatments are commonly used for functional dyspepsia as well as organic dyspepsia and are available through various distribution channels, including retail pharmacies, hospital pharmacies, and online pharmacies.
The functional dyspepsia drug market research report is one of a series of new reports from The Business Research Company that provides functional dyspepsia drug market statistics, including the functional dyspepsia drug industry's global market size, regional shares, competitors with a functional dyspepsia drug market share, detailed functional dyspepsia drug market segments, market trends and opportunities, and any further data you may need to thrive in the functional dyspepsia drug industry. This functional dyspepsia drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The functional dyspepsia drug market size has grown strongly in recent years. It will grow from $8.56 billion in 2024 to $9.15 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth during the historic period can be attributed to the increasing prevalence of various associated risk factors, higher healthcare expenditure, a rise in dyspeptic cases, a growing number of gastrointestinal disorders, and an expanding aging population.
The functional dyspepsia drug market size is expected to see strong growth in the next few years. It will grow to $11.80 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth during the forecast period can be attributed to the rising consumer preference for holistic and lifestyle-based approaches, a growing preference for combination therapies, increased adoption of lifestyle modifications, expanding research on the gut-brain axis, and a higher use of non-pharmacological interventions. Key trends expected in this period include advancements in drug formulation, collaborations between healthcare providers and pharmaceutical companies, a shift toward precision medicine approaches, the integration of telemedicine and digital health technologies, and personalized medicine strategies.
The increase in alcohol consumption is expected to boost the growth of the functional dyspepsia drug market. Alcohol, found in beverages such as beer, wine, and spirits, is composed of ethanol, which affects the central nervous system and can cause intoxication when consumed. The rising consumption of alcohol is driven by factors such as social and cultural acceptance, stress relief, easy availability, and aggressive marketing by alcoholic beverage companies. Functional dyspepsia drugs are used to alleviate alcohol-induced gastric discomfort by reducing acid production and improving digestive function. For example, a report published by the Office for Health Improvement & Disparities (OHID) in March 2023, a UK-based government agency, revealed that between 2021 and 2022, there were 342,795 hospital admissions related solely to alcohol, leading to a rate of 626 admissions per 100,000 people. Thus, the increase in alcohol consumption is contributing to the growth of the functional dyspepsia drug market.
The rise in the prevalence of metabolic disorders is expected to drive the expansion of the functional dyspepsia drug market. A metabolic disorder occurs when the body's normal metabolic processes are disrupted, leading to an imbalance in the processing of nutrients, energy, or waste. Factors such as poor diet, sedentary lifestyles, genetic predispositions, and rising obesity rates contribute to the growing prevalence of these disorders. Functional dyspepsia drugs are used to manage gastrointestinal symptoms and improve digestive function in individuals with metabolic disorders. For instance, a report published by the World Health Organization (WHO) in November 2024 stated that 14% of adults aged 18 and older were diagnosed with diabetes in 2022. Therefore, the rising prevalence of metabolic disorders is driving the growth of the functional dyspepsia drug market.
Leading companies in the functional dyspepsia drug market are focusing on clinical trials to develop innovative therapies that address the underlying causes of the condition, improve treatment effectiveness, and meet patient needs. Clinical trials are crucial for assessing the safety, efficacy, and optimal treatment strategies for functional dyspepsia drugs. For example, in December 2022, electroCore Inc., a US-based medical technology company, announced that the United States Patent and Trademark Office (USPTO) granted two patents for its innovative non-invasive vagus nerve stimulation (nVNS) technology. The first patent, U.S. Patent No. 11,511,109, covered a method for treating gastrointestinal disorders, including functional dyspepsia, using vagus nerve stimulation. The second patent, U.S. Patent No. 11,511,110, involved a system for delivering non-invasive electrical stimulation to the vagus nerve. These patents reinforced electroCore's position in advancing non-invasive neuromodulation therapies.
Major players in the functional dyspepsia drug market are Pfizer Inc., Abbvie Inc., Bayer AG, AstraZeneca plc, Astellas Pharma Inc., Eisai Co. Ltd., Menarini Group, Dr. Reddy's Laboratories Ltd., Lupin Limited, Daewoong Pharmaceutical Co. Ltd., Phathom Pharmaceuticals, Zeria Pharmaceutical Co. Ltd., Ironwood Pharmaceuticals Inc., Salix Pharmaceuticals Inc., RedHill Biopharma, RaQualia Pharma Inc., MetaMe Health, Renexxion LLC, Processa Pharmaceuticals, and Evoke Pharma Inc.
North America was the largest region in the functional dyspepsia drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in functional dyspepsia drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the functional dyspepsia drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The functional dyspepsia drug market consists of sales of mucosal protectants, neuromodulators, serotonin modulators, and herbal drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Functional Dyspepsia Drug Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on functional dyspepsia drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for functional dyspepsia drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The functional dyspepsia drug market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Drug Type: Proton Pump Inhibitors; H-2-Receptor Antagonists; Antacids; Antibiotics; Prokinetics; Antidepressants
- 2) By Indication: Functional Dyspepsia; Organic Dyspepsia
- 3) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Online Pharmacies
- Subsegments:
- 1) By Proton Pump Inhibitors: Omeprazole; Esomeprazole; Lansoprazole; Pantoprazole; Rabeprazole
- 2) By H-2-Receptor Antagonists: Ranitidine; Famotidine; Cimetidine; Nizatidine
- 3) By Antacids: Aluminum Hydroxide; Magnesium Hydroxide; Calcium Carbonate; Sodium Bicarbonate
- 4) By Antibiotics: Clarithromycin; Amoxicillin; Metronidazole; Tetracycline
- 5) By Prokinetics: Domperidone; Metoclopramide; Itopride; Mosapride
- 6) By Antidepressants: Tricyclic Antidepressants; Selective Serotonin Reuptake Inhibitors; Serotonin-Norepinephrine Reuptake Inhibitors
- Companies Mentioned: Pfizer Inc.; Abbvie Inc.; Bayer AG; AstraZeneca plc; Astellas Pharma Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Functional Dyspepsia Drug Market Characteristics
3. Functional Dyspepsia Drug Market Trends And Strategies
4. Functional Dyspepsia Drug Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Functional Dyspepsia Drug Growth Analysis And Strategic Analysis Framework
- 5.1. Global Functional Dyspepsia Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Functional Dyspepsia Drug Market Growth Rate Analysis
- 5.4. Global Functional Dyspepsia Drug Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Functional Dyspepsia Drug Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Functional Dyspepsia Drug Total Addressable Market (TAM)
6. Functional Dyspepsia Drug Market Segmentation
- 6.1. Global Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Proton Pump Inhibitors
- H-2-Receptor Antagonists
- Antacids
- Antibiotics
- Prokinetics
- Antidepressants
- 6.2. Global Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Functional Dyspepsia
- Organic Dyspepsia
- 6.3. Global Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- 6.4. Global Functional Dyspepsia Drug Market, Sub-Segmentation Of Proton Pump Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Omeprazole
- Esomeprazole
- Lansoprazole
- Pantoprazole
- Rabeprazole
- 6.5. Global Functional Dyspepsia Drug Market, Sub-Segmentation Of H-2-Receptor Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Ranitidine
- Famotidine
- Cimetidine
- Nizatidine
- 6.6. Global Functional Dyspepsia Drug Market, Sub-Segmentation Of Antacids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Aluminum Hydroxide
- Magnesium Hydroxide
- Calcium Carbonate
- Sodium Bicarbonate
- 6.7. Global Functional Dyspepsia Drug Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Clarithromycin
- Amoxicillin
- Metronidazole
- Tetracycline
- 6.8. Global Functional Dyspepsia Drug Market, Sub-Segmentation Of Prokinetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Domperidone
- Metoclopramide
- Itopride
- Mosapride
- 6.9. Global Functional Dyspepsia Drug Market, Sub-Segmentation Of Antidepressants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tricyclic Antidepressants
- Selective Serotonin Reuptake Inhibitors
- Serotonin-Norepinephrine Reuptake Inhibitors
7. Functional Dyspepsia Drug Market Regional And Country Analysis
- 7.1. Global Functional Dyspepsia Drug Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Functional Dyspepsia Drug Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Functional Dyspepsia Drug Market
- 8.1. Asia-Pacific Functional Dyspepsia Drug Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Functional Dyspepsia Drug Market
- 9.1. China Functional Dyspepsia Drug Market Overview
- 9.2. China Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Functional Dyspepsia Drug Market
- 10.1. India Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Functional Dyspepsia Drug Market
- 11.1. Japan Functional Dyspepsia Drug Market Overview
- 11.2. Japan Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Functional Dyspepsia Drug Market
- 12.1. Australia Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Functional Dyspepsia Drug Market
- 13.1. Indonesia Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Functional Dyspepsia Drug Market
- 14.1. South Korea Functional Dyspepsia Drug Market Overview
- 14.2. South Korea Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Functional Dyspepsia Drug Market
- 15.1. Western Europe Functional Dyspepsia Drug Market Overview
- 15.2. Western Europe Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Functional Dyspepsia Drug Market
- 16.1. UK Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Functional Dyspepsia Drug Market
- 17.1. Germany Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Functional Dyspepsia Drug Market
- 18.1. France Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Functional Dyspepsia Drug Market
- 19.1. Italy Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Functional Dyspepsia Drug Market
- 20.1. Spain Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Functional Dyspepsia Drug Market
- 21.1. Eastern Europe Functional Dyspepsia Drug Market Overview
- 21.2. Eastern Europe Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Functional Dyspepsia Drug Market
- 22.1. Russia Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Functional Dyspepsia Drug Market
- 23.1. North America Functional Dyspepsia Drug Market Overview
- 23.2. North America Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Functional Dyspepsia Drug Market
- 24.1. USA Functional Dyspepsia Drug Market Overview
- 24.2. USA Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Functional Dyspepsia Drug Market
- 25.1. Canada Functional Dyspepsia Drug Market Overview
- 25.2. Canada Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Functional Dyspepsia Drug Market
- 26.1. South America Functional Dyspepsia Drug Market Overview
- 26.2. South America Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Functional Dyspepsia Drug Market
- 27.1. Brazil Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Functional Dyspepsia Drug Market
- 28.1. Middle East Functional Dyspepsia Drug Market Overview
- 28.2. Middle East Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Functional Dyspepsia Drug Market
- 29.1. Africa Functional Dyspepsia Drug Market Overview
- 29.2. Africa Functional Dyspepsia Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Functional Dyspepsia Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Functional Dyspepsia Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Functional Dyspepsia Drug Market Competitive Landscape And Company Profiles
- 30.1. Functional Dyspepsia Drug Market Competitive Landscape
- 30.2. Functional Dyspepsia Drug Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Functional Dyspepsia Drug Market Other Major And Innovative Companies
- 31.1. Eisai Co. Ltd.
- 31.2. Menarini Group
- 31.3. Dr. Reddy's Laboratories Ltd.
- 31.4. Lupin Limited
- 31.5. Daewoong Pharmaceutical Co. Ltd.
- 31.6. Phathom Pharmaceuticals
- 31.7. Zeria Pharmaceutical Co. Ltd.
- 31.8. Ironwood Pharmaceuticals Inc.
- 31.9. Salix Pharmaceuticals Inc.
- 31.10. RedHill Biopharma
- 31.11. RaQualia Pharma Inc.
- 31.12. MetaMe Health
- 31.13. Renexxion LLC
- 31.14. Processa Pharmaceuticals
- 31.15. Evoke Pharma Inc.
32. Global Functional Dyspepsia Drug Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Functional Dyspepsia Drug Market
34. Recent Developments In The Functional Dyspepsia Drug Market
35. Functional Dyspepsia Drug Market High Potential Countries, Segments and Strategies
- 35.1 Functional Dyspepsia Drug Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Functional Dyspepsia Drug Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Functional Dyspepsia Drug Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
